Is there a better way than banning sale of syringes to curb the spread of drug abuse?

M Neelam Kachhap
M Neelam Kachhap
· 1 min read
Restriction on sale of syringe

Can you stop drug addiction by restricting the sale of syringes, asked industry experts after some districts in Punjab imposed complete ban on sale of syringes without prescription.

At least three district administrations, Faridkot, Bathinda and Fazilka have issued directives to medical stores to not sell syringes without a doctor’s written prescription.  The order issued by the deputy commissioner using the power under section 144 of CrPC will come into effect immediately and last till september 30, 2018.

“While the intent of solving a problem may be noble but the tool being used to manage the problem is questionable.This will amplify problem of Syringes reuse by Drug Addicts and accelerate spread of Hepatitis C in Punjab which already has highest Hepatitis B&C spreading from Drug Addicts to other patients in the already challenged healthcare system. Instead of Restriction to syringes access it would be more prudent to accelerate a switch to Auto Disable Syringes in Punjab and have a State policy similar to the one by Government of Andhra Pradesh to prevent reuse with the help of State Drug Controller to address this magnifying problem,” said Rajiv Nath, Forum Coordinator Association of Indian Medical Device Industry (AIMED).

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk